Lipids and Familial Hyperlipidaemia
These meetings are intended for UK Healthcare Professionals and have been developed in accordance with the ABPI Code of Practice.
PM Healthcare events are Quality Assured by the University of Bradford
| Satellite | Lipids and Familial Hyperlipidaemia | |||
| Speakers | Helen Williams (Consultant Pharmacist-Cardiovascular Disease at NHS Lambeth CCG: Consultant Pharmacist for Cardiovascular Disease, South London at NHS Southwark CCG) | |||
| Satellite Description | ||||
|
This session will review the revised Familial Hypercholesterolaemia guidance issued by NICE in 2017 and its implication for practice. The role of PCSK9 inhibitors in lipid management, including new data on cardiovascular outcomes, will be highlighted, as will the possible impact of new drugs / drug classes currently in development. | ||||
